Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2009 1
2011 5
2012 1
2013 3
2014 3
2015 2
2016 1
2017 2
2018 5
2019 3
2020 6
2021 6
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Genetic susceptibility to lung cancer.
Sugimura H, Tao H, Suzuki M, Mori H, Tsuboi M, Matsuura S, Goto M, Shinmura K, Ozawa T, Tanioka F, Sato N, Matsushima Y, Kageyama S, Funai K, Chou PH, Matsuda T. Sugimura H, et al. Among authors: matsuura s. Front Biosci (Schol Ed). 2011 Jun 1;3(4):1463-77. doi: 10.2741/237. Front Biosci (Schol Ed). 2011. PMID: 21622282 Free article. Review.
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study.
Karayama M, Inui N, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Ikeda M, Matsuda H, Inami N, Kaida Y, Funayama S, Ichikawa S, Goshima S, Suda T. Karayama M, et al. Among authors: matsuura s. J Immunother Cancer. 2023 Jul;11(7):e007056. doi: 10.1136/jitc-2023-007056. J Immunother Cancer. 2023. PMID: 37500182 Free PMC article. Clinical Trial.
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
Inoue Y, Inui N, Karayama M, Asada K, Fujii M, Matsuura S, Uto T, Hashimoto D, Matsui T, Ikeda M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T. Inoue Y, et al. Among authors: matsuura s. Cancer Immunol Immunother. 2023 Aug;72(8):2717-2728. doi: 10.1007/s00262-023-03453-z. Epub 2023 Apr 26. Cancer Immunol Immunother. 2023. PMID: 37099186 Free PMC article.
Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Koda K, Enomoto Y, Aoshima Y, Amano Y, Kato S, Hasegawa H, Matsui T, Yokomura K, Mochizuki E, Matsuura S, Koshimizu N, Morita M, Kojima S, Watanabe A, Oyama Y, Ikeda M, Kusagaya H, Uto T, Sato J, Imokawa S, Kono M, Hashimoto D, Kamiya Y, Toyoshima M, Asada K, Morita M, Mikamo M, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T. Koda K, et al. Among authors: matsuura s. Ther Adv Chronic Dis. 2022 Jun 28;13:20406223221108395. doi: 10.1177/20406223221108395. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35782342 Free PMC article.
Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Tanaka K, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kusagaya H, Matsuura S, Uto T, Hashimoto D, Matsui T, Asada K, Suda T. Tanaka K, et al. Among authors: matsuura s. Cancer Chemother Pharmacol. 2019 Jul;84(1):147-153. doi: 10.1007/s00280-019-03868-5. Epub 2019 May 13. Cancer Chemother Pharmacol. 2019. PMID: 31087137 Clinical Trial.
Sinobronchial allergic mycosis syndrome in an elderly male.
Mochizuki E, Matsuura S, Kubota T, Mochizuka Y, Oishi K, Naoi H, Uehara M, Mikura S, Nagaoka M, Tsukui M, Koshimizu N, Nameki I. Mochizuki E, et al. Among authors: matsuura s. Allergy Asthma Clin Immunol. 2019 Jun 4;15:35. doi: 10.1186/s13223-019-0349-y. eCollection 2019. Allergy Asthma Clin Immunol. 2019. PMID: 31171926 Free PMC article.
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
Miyashita K, Karayama M, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kono M, Matsui T, Niwa M, Koda K, Toyoshima M, Matsushima S, Matsuura S, Asada K, Fujii M, Kusagaya H, Matsuda H, Inui N, Suda T. Miyashita K, et al. Among authors: matsuura s. BMC Pulm Med. 2021 Oct 2;21(1):309. doi: 10.1186/s12890-021-01681-6. BMC Pulm Med. 2021. PMID: 34600514 Free PMC article.
47 results